In the News January 20, 2016

Bloomberg BNA | Outlook 2016: Lab Tests, Cybersecurity, Off-Label Use Among Top Device Issues

Peter Kazon is quoted on the Food and Drug Administration’s focus to regulate laboratory-developed tests (LDTs) amid uncertainty over the agency’s final LDT guidance.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.